Navigation Links
Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
Date:5/4/2012

y mouth, nausea, diarrhea, anxiety and anorexia.

Please see Full Prescribing Information for Vyvanse (lisdexamfetamine dimesylate), including Boxed WARNING regarding Potential for Misuse, Abuse, Addiction, and Diversion.

ABOUT INTUNIV (guanfacine) EXTENDED RELEASE TABLETS

INDICATION

INTUNIV (guanfacine) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications in children and adolescents ages 6 to 17. The effectiveness of INTUNIV for more than 9 weeks has not been systematically evaluated. The physician electing to use INTUNIV for extended periods should periodically reevaluate its long-term usefulness for the individual patient.

INTUNIV is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

IMPORTANT SAFETY INFORMATION

Patients with a history of hypersensitivity to INTUNIV, its inactive ingredients, or other products containing guanfacine (eg, TENEX®) should not take INTUNIV.

Hypotension, bradycardia, and syncope were observed in clinical trials. Use INTUNIV with caution in treating patients who have experienced hypotension, heart block, bradycardia, or syncope, or who may have a condition that predisposes them to syncope; are treated concomitantly with antihypertensives or other drugs that can reduce blood pressure or heart rate or increase the risk of syncope. Heart rate and blood pressure should be measured prior to initiation of therapy, following dose increases, and periodically while on therapy. Advise patients to avoid becoming dehydrated or overheated.

Somnolence and sedation were commonly reported adverse reactions in clinical studies (38% for INTUNIV
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... is expected to reach USD 24.7 billion by ... View Research Inc. Growing prevalence of neurological and ... equipments market over the forecast period. The presence ... and cryotherapy, advancement in the technologies coupled with ...
(Date:8/3/2015)... 3, 2015 Biosensors International Group, Ltd. ... BIOS.SI; SGX: B20), a developer, manufacturer and marketer ... for its first fiscal quarter ended 30 June ... and Recent Developments: , Biosensors ... cost structure, driven by lower operating expenses and ...
(Date:8/3/2015)... , Aug. 3, 2015  CytomX, a ... of cancer, today announced the promotion of several ... Debanjan Ray , who previously served as vice ... been promoted to senior vice president of corporate ... Ray held positions as the vice president of ...
Breaking Medicine Technology:Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3
... N.J., Jan. 19, 2011 Today, Novo Nordisk announced ... for the Eastern District of Michigan issued an adverse ... US Patent No. 6,677,358. The district court ruled that ... and metformin for the treatment of type 2 diabetes, ...
... Progressive Medical, Inc., a leading pharmacy benefit manager and ... no-faulty auto industries, has named Kevin Banion as chief ... as president of Progressive Medical. This strategic move for ... Bianconi recently announced that he will serve as chairman ...
Cached Medicine Technology:Kevin Banion Named CEO of Progressive Medical, Inc. 2
(Date:8/3/2015)... ... ... Bayer has agreed to pay $56.9 million to set up a settlement program ... suffered an arterial blood clot including stroke and heart attack. The litigation involving product ... ongoing for well-over five years. In 2009, lawsuits filed against Bayer involving Yaz, Yasmin ...
(Date:8/3/2015)... ... 03, 2015 , ... Pitt Researchers to Monitor Resistance to ... School of Medicine are leading a five-year, $5 million initiative to monitor drug ... A cooperative agreement awarded by the U.S. Agency for International Development (USAID), will ...
(Date:8/3/2015)... ... 03, 2015 , ... A recent survey by the ... Hispanics believe people can positively affect their diabetes, few look beyond diet changes ... diet changes was important. Far fewer participants mentioned the need for exercise (30%), ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dental practice in Los Angeles , Sunset ... people know that general health emergencies, such as broken arms or a heart attack, ... where to turn to during a dental emergency. This is important, because dental trauma ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... The art ... experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely ... has decided to share her cookbook Recipes from My Persian Kitchen with the world. ...
Breaking Medicine News(10 mins):Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2
... University determined that immune responses to the tetanus vaccine ... (MTX) was compared with MTX alone in patients with ... (Pneumovax pneumonia vaccine), however, were reduced in RA patients ... published in the January 2010 issue of Arthritis ...
... SODA project has created a service-oriented ecosystem for ... software components in even low-cost devices in the ... of device to communicate using the same language ... will be in a wide range of applications ...
... and others interested in the chemical sciences are invited ... Chemical Society (ACS) Webinars, Your Career Matters! featuring speakers ... science and engineering professionals. Scheduled for Thursday, Jan. ... webinar will feature ACS President Joseph S. Francisco, Ph.D., ...
... ,A new study shows that poor lung function during ... including birth weight, height, and gender. Researchers from Newcastle University ... all aged 14 years. Follow-up data also were obtained for ... showed that several factors were related to poorer lung function ...
... Mayo Clinic research study published in the January issue of ... that St. John,s wort is not an effective treatment for ... treat IBS, to date, no study has examined the success ... IBS. "Our study investigated if herbal antidepressants such as ...
... of a neuronal protein, researchers halted the growth of ... findings are reported online in the Journal of ... Formerly known for its effects on neuronal growth, ... produced by cells in human blood vessels. By diminishing ...
Cached Medicine News:Health News:Immune responses to tetanus vaccine unchanged for RA patients on rituximab 2Health News:Service-oriented ecosystem enables low cost devices to form interactive 'web of objects' 2Health News:Service-oriented ecosystem enables low cost devices to form interactive 'web of objects' 3Health News:ACS Webinar features tips for using a chemistry degree in finding career opportunities 2Health News:News briefs from the January issue of Chest 2Health News:St. John's wort not helpful treatment for irritable bowel syndrome, Mayo Clinic researchers say 2
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
... Surgical Hemostats First Stop absorbable collagen ... that offers superior handling and removal characteristics. ... and tailored to fit the wound. FirstStop ... can easily be peeled away after hemostasis ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: